152 related articles for article (PubMed ID: 15133847)
1. Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.
Nan KJ; Jing Z; Gong L
World J Gastroenterol; 2004 May; 10(10):1425-30. PubMed ID: 15133847
[TBL] [Abstract][Full Text] [Related]
2. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
5. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.
Zhou Q; He Q; Liang LJ
World J Gastroenterol; 2003 Nov; 9(11):2450-4. PubMed ID: 14606074
[TBL] [Abstract][Full Text] [Related]
6. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.
Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF
Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245
[TBL] [Abstract][Full Text] [Related]
7. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
8. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
[TBL] [Abstract][Full Text] [Related]
9. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
10. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
Qin J; Wang Z; Wang Y; Ma L; Ni Q; Ke J
Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated p27Kip1 on Thr157 is an important prognosis in human hepatocellular carcinoma in vivo and in vitro.
He S; Lu M; Xue W; Wang Y; Zhao Y; Gao S; Ke Q; Liu Y; Li P; Cui X; Cheng C; Shen A
Med Oncol; 2011 Mar; 28(1):94-104. PubMed ID: 20108172
[TBL] [Abstract][Full Text] [Related]
13. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
14. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
[TBL] [Abstract][Full Text] [Related]
17. p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.
Armengol C; Boix L; Bachs O; Solé M; Fuster J; Sala M; Llovet JM; Rodés J; Bruix J
J Hepatol; 2003 May; 38(5):591-7. PubMed ID: 12713869
[TBL] [Abstract][Full Text] [Related]
18. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
[TBL] [Abstract][Full Text] [Related]
19. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
20. p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis.
Yachida S; Sakamoto M; Imaida K; Yokohira M; Saoo K; Okano K; Wakabayashi H; Maeta H; Suzuki Y
Cancer Sci; 2008 Nov; 99(11):2152-9. PubMed ID: 18808421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
